Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Study: 31% of Americans had been infected with SARS-CoV-2 by the end of 2020

A new study published in the journal Nature estimates that 103 million Americans, or 31 percent of the U.S. population, had been infected with SARS-CoV-2 by the end of 2020.

27 Aug 2021

Pediatric cancer patients fare worse with COVID-19 than children without cancer

Research from a large international effort shows that 20% of children with cancer who are infected with SARS-CoV-2 develop severe infections.

27 Aug 2021

COVID-19 pandemic illuminates the importance of airborne transmission of respiratory viruses

SARS-CoV-2, the virus behind today's global coronavirus pandemic, spreads primarily by inhalation of virus-laden aerosols at both short and long ranges -;and a comprehensive new assessment of respiratory viruses finds that many others probably do as well.

27 Aug 2021

Improved understanding of aerosol transmission could help control airborne respiratory viruses

The COVID-19 pandemic has revealed critical knowledge gaps and assumptions concerning how respiratory viruses spread between hosts.

27 Aug 2021

Pregnant women with COVID-19 are more susceptible to pre-eclampsia

A review of the scientific literature published by Brazilian researchers shows that pregnant women infected by the novel coronavirus run a higher risk of developing pre-eclampsia, a pregnancy complication characterized by persistent high blood pressure, usually in the second half of pregnancy or shortly after delivery.

26 Aug 2021

Preliminary study suggests nitric oxide may be a potential treatment for COVID-19 respiratory failure

New research led by Devang K. Sanghavi of the Mayo Clinic in Florida, USA, suggests pre-intubation use of nitric oxide for patients with COVID-19–related hypoxemic respiratory may help reduce patients' mortality. Their findings show that inhaling nitric oxide in this patient population could reduce the need for future intubation and other invasive mechanical ventilation.

26 Aug 2021

German study shows high protection from COVID-19 in over 80s with Pfizer vaccine

A new observational study in Germany, recently published on the medRxiv* preprint server, found the Comirnaty vaccine to be 68.3% effective against COVID-19 for people over 80. In those fully immunized, the vaccine was found to be 73.2% effective in preventing hospitalization and 80.1% effective against death.

26 Aug 2021

Oral mucosa identified as potential target for SARS-CoV-2 infection

A recent study suggested that ACE2 receptors are expressed in oral tissues, making the oral cavity an important potential entry point of SARS-CoV-2.

26 Aug 2021

New Montana law sows confusion, defiance over school quarantines

As classes get underway this week and next, Montana school and county health officials are grappling with how a new state law that bans vaccine discrimination should apply to quarantine orders for students and staffers exposed to covid-19.

26 Aug 2021

Potential variant of interest in South Africa assigned to the PANGO lineage C.1.2

Continual genomic surveillance of the SARS-CoV-2 strains in South Africa has revealed an increase in the number of sequences belonging to C.1 lineage during the third wave (May 2021) of SARS-CoV-2 infections. This observation was unexpected because C.1 was last reported in January 2021.

26 Aug 2021

The influence of COVID-19 on platelet activation and aggregation

In a paper recently uploaded to the bioRxiv* preprint server, humanized ACE2 mice are infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and platelets are subsequently isolated from the blood for quantitative proteomic analysis.

26 Aug 2021

Scientists assess SARS-CoV-2 mutants in ferret hosts

In a paper recently uploaded to the preprint server bioRxiv* by the cause of SARS-CoV-2 mutations observed in mink and ferrets is investigated, and the danger posed by such mutations to humans assessed.

26 Aug 2021

Large UK study examines impact of Delta variant on viral burden and vaccine effectiveness

Now, a new study published on the medRxiv* preprint server focused on determining the effectiveness of the BNT162b2, ChAdOx1, and mRNA-1273 vaccines by conducting SARS-CoV-2 PCR-positive tests.

26 Aug 2021

Two mRNA vaccines are effective even without post-shot symptoms or prior SARS-CoV-2 infection

Vaccination with the two messenger RNA (mRNA) vaccines for SARS-CoV-2, the virus that causes COVID-19, yields a robust antibody response, even if a person did not develop significant symptoms following vaccination or did not have a prior SARS-CoV-2 infection.

26 Aug 2021

Johns Hopkins experts share tips to protect kids heading back to school

Children across the nation are heading back to school, a time of year that can bring a variety of emotions from excitement to anxiety.

26 Aug 2021

Hyfe’s smartphone cough-tracking app used in a groundbreaking epidemiological research

Hyfe, a cough monitoring smartphone app and digital diagnostics tool developed by an international team of scientists and public health professionals, recently announced that their technology is now being incorporated into groundbreaking research in Spain in partnership with the University of Navarra, and involving over 800 participants.

26 Aug 2021

Could soluble CD24 offer some hope against severe COVID-19?

A recent randomized phase III trial conducted by researchers at the Ohio State University, Columbus, OH, US, evaluated the impact of CD24Fc in severe COVID-19 patients and showed promising clinical efficacy. This study is available as a preprint on the medRxiv* server.

26 Aug 2021

Study examines impact of COVID pandemic on birth outcomes in Wales

Researchers in the UK have looked at the impact of the COVID-19 (coronavirus disease 2019) pandemic on the population birth outcomes in 2020, detailing the experiences of the expectant mothers from immunization rates for babies to self-reported levels of stress and anxiety in the mothers, compared to pre-COVID years.

25 Aug 2021

SARS-CoV-2 alpha variant increased COVID-19 severity in Scotland's 3rd wave

A team of UK-based scientists has recently revealed that the alpha variant (B.1.1.7) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the third pandemic wave in Scotland and that the variant is associated with more severe coronavirus disease 2019 (COVID-19). The study is currently available on the medRxiv* preprint server.

25 Aug 2021

Child mortality in England dropped significantly during COVID-19 pandemic

In a study conducted at Cardiff University and the University of Bristol, UK, scientists have observed that in England, the all-cause child mortality rate has dropped significantly during the first year of coronavirus disease 2019 (COVID-19) pandemic compared to that in the pre-pandemic year. The highest reduction in mortality rate has been observed in children under the age of 10 years. The study is currently available on the medRxiv* preprint server.

25 Aug 2021

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Study: 31% of Americans had been infected with SARS-CoV-2 by the end of 2020

Pediatric cancer patients fare worse with COVID-19 than children without cancer

COVID-19 pandemic illuminates the importance of airborne transmission of respiratory viruses

Improved understanding of aerosol transmission could help control airborne respiratory viruses

Pregnant women with COVID-19 are more susceptible to pre-eclampsia

Preliminary study suggests nitric oxide may be a potential treatment for COVID-19 respiratory failure

German study shows high protection from COVID-19 in over 80s with Pfizer vaccine

Oral mucosa identified as potential target for SARS-CoV-2 infection

New Montana law sows confusion, defiance over school quarantines

Potential variant of interest in South Africa assigned to the PANGO lineage C.1.2

The influence of COVID-19 on platelet activation and aggregation

Scientists assess SARS-CoV-2 mutants in ferret hosts

Large UK study examines impact of Delta variant on viral burden and vaccine effectiveness

Two mRNA vaccines are effective even without post-shot symptoms or prior SARS-CoV-2 infection

Johns Hopkins experts share tips to protect kids heading back to school

Hyfe’s smartphone cough-tracking app used in a groundbreaking epidemiological research

Could soluble CD24 offer some hope against severe COVID-19?

Study examines impact of COVID pandemic on birth outcomes in Wales

SARS-CoV-2 alpha variant increased COVID-19 severity in Scotland's 3rd wave

Child mortality in England dropped significantly during COVID-19 pandemic

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in